CCL2 and central nervous system cancer: To analyze which cells co-localized with CCL2+ or CXL10+ cells in the glioma model, we used the stem cell marker Nestin, a microglia marker Iba-1, and the M1- and M2-type monocyte macrophage markers CD16 and CD163, respectively.